Alembic Pharmaceuticals Ltd. is a high-risk company in the pharmaceutical industry based in India. Specializing in the manufacturing and marketing of generic drugs worldwide, Alembic also has a branded formulation business that focuses on therapeutic areas like dermatology, oncology, ophthalmology, and injectable formulations. The company's growth strategy includes potential mergers and acquisitions to enhance research, development, manufacturing, and marketing capabilities. With an ESG score of 33.7, investments in Alembic Pharmaceuticals Ltd. may present both opportunities and risks for investors.